Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $17,743 - $37,654
2,928 New
2,928 $18,000
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $70,612 - $132,860
-4,161 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $84,000 - $137,038
3,280 Added 372.3%
4,161 $130,000
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $17,311 - $24,659
881 New
881 $20,000
Q1 2021

May 17, 2021

SELL
$18.08 - $28.8 $18,857 - $30,038
-1,043 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$11.7 - $23.41 $3,416 - $6,835
292 Added 38.88%
1,043 $23,000
Q3 2020

Nov 16, 2020

BUY
$11.21 - $13.82 $8,418 - $10,378
751 New
751 $9,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.